当前位置: 首页 > 期刊 > 《中国当代医药》 > 202010
编号:13487782
核因子κB与过氧化物酶体增殖物激活受体γ在类风湿性关节炎发病机制中的研究进展(5)
http://www.100md.com 2020年4月5日 《中国当代医药》 202010
     [29]Akune T,Ohba S,Kamekura S,et al.PPAR-γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors[J].J Clin Invest,2004,113(6):846-855.

    [30]Wan Y,Evans RM,Chong LW.PPAR-gamma regulates osteoclastogenesis in mice[J].Nat Med,2007,13(12):1496-1503.

    [31]Zou W,Rohatgi N,Chen TH,et al.PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation[J].Nat Med,2016,22(11):1203-1205.

    [32]Zhuang H,Zhang X,Zhu C,et al.Molecular mechanisms of PPAR-γ governing MSC osteogenic and adipogenic differentiation[J].Curr Stem Cell Res Ther,2016,11(3):255-264.

    [33]Nencioni A,Wesselborg S,Brossart P.Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses[J].Crit Rev Immunol,2003, 23(1-2):1-13.

    [34]Bhat OM,Kumar PU,Rao KR,et al.Terminalia arjuna prevents interleukin-18-induced atherosclerosis via modulation of NF-κB/PPAR-γ mediated pathway in Apo E-mice[J].Inflammopharmacology,2017,26(2):583-589.

    [35]賈伟伟,刘春景.类风湿关节炎临床研究进展[J].新疆中医药,2017,35(5):145-149.

    (收稿日期:2019-08-15 本文编辑:任秀兰), http://www.100md.com(董建斌 李金田 张毅)
上一页1 2 3 4 5